Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.
Clinical trial NCT04750824 · COMPLETED
Trial details
- NCT number
- NCT04750824
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-12-20
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.